
Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062)
Author(s) -
K. H. Moore,
R. H. Raasch,
K. L. Brouwer,
K. Opheim,
Sarah H. Cheeseman,
E. Eyster,
S. M. Lemon,
Charles M. van der Horst
Publication year - 1995
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/6vc5-dj27
Subject(s) - zidovudine , bioavailability , pharmacokinetics , metabolite , medicine , pharmacology , human immunodeficiency virus (hiv) , clinical trial , disease , virology , immunology , viral disease